AJP - Cell Physiology, Vol 253, Issue 6 C766-C773, Copyright © 1987 by American Physiological Society

ARTICLES

Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle

L. L. Moldawer, G. Svaninger, J. Gelin and K. G. Lundholm
Department of Surgery I, Sahlgrenska Hospital, University of Gothenburg, Sweden.

Recent studies have claimed that interleukin 1-containing preparations increase skeletal protein degradation similar to that seen during infection and inflammation. However, preparations employed have contained other products of activated macrophages, including tumor necrosis factor-alpha. In the present report, we investigated the capability of recombinant-derived murine and human interleukins 1-alpha and 1-beta and human tumor necrosis factor-alpha to affect skeletal protein synthesis and degradation both in vitro and in vivo. Partially purified products of Staphylococcus albus-stimulated human blood monocytes increased skeletal protein degradation both in vivo and in vitro. However, none of the recombinant interleukin 1 nor the human tumor necrosis factor-alpha preparations had any impact on skeletal protein balance. Both recombinant interleukin 1 and tumor necrosis factor-alpha stimulated the production of prostaglandin E2 (PGE2). Furthermore, a polyclonal antibody to human interleukin 1 eliminated the lymphoproliferative response to partially purified monocyte preparations (interleukin 1 activity), but failed to abrogate the increased skeletal protein degradation in vitro. This study demonstrates that although interleukin 1 and tumor necrosis factor-alpha induce a PGE2 response by skeletal muscle in vitro, some macrophage product distinct from either interleukin 1 or tumor necrosis factor-alpha is responsible for the accelerated skeletal protein degradation seen with partially purified human blood monocyte products. Elevated PGE2 levels do not appear to regulate skeletal protein balance in vitro.

This article has been cited by other articles:

				M. L. Shumate, G. Yumet, T. A. Ahmed, and R. N. Cooney Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G227 - G239. [Abstract] [Full Text] [PDF]

				G. Yumet, M. L. Shumate, P. Bryant, C.-M. Lin, C. H. Lang, and R. N. Cooney Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E472 - E481. [Abstract] [Full Text] [PDF]

				D. C. Guttridge, M. W. Mayo, L. V. Madrid, C.-Y. Wang, and A. S. Baldwin Jr. NF-kappa B-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia Science, September 29, 2000; 289(5488): 2363 - 2366. [Abstract] [Full Text]

				B. K. Pedersen and L. Hoffman-Goetz Exercise and the Immune System: Regulation, Integration, and Adaptation Physiol Rev, July 1, 2000; 80(3): 1055 - 1081. [Abstract] [Full Text] [PDF]

				A. M. van HEECKEREN, J. TSCHEIKUNA, R. W. WALENGA, M. W. KONSTAN, P. B. DAVIS, B. EROKWU, M. A. HAXHIU, and T. W. FERKOL Effect of Pseudomonas Infection on Weight Loss, Lung Mechanics, and Cytokines in Mice Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 271 - 279. [Abstract] [Full Text]

				R. Cooney, S. R. Kimball, R. Eckman, G. Maish III, M. Shumate, and T. C. Vary TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E611 - E619. [Abstract] [Full Text] [PDF]

				C. H. Lang, R. A. Frost, A. C. Nairn, D. A. MacLean, and T. C. Vary TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E336 - E347. [Abstract] [Full Text] [PDF]